(Q40275334)

19 September 2017

Transcription levels of invasion-related genes in prostate cancer cells are modified by inhibitors of tyrosine kinase (English)

1 reference

19 September 2017

4

Jostein Halgunset

1 reference

19 September 2017

Haakon Skogseth

1

1 reference

PubMed ID

16725013

19 September 2017

Turid Follestad

series ordinal

2

1 reference

PubMed ID

16725013

19 September 2017

Erik Larsson

series ordinal

3

1 reference

19 September 2017

1 May 2006

1 reference

Acta Pathologica et Microbiologica Scandinavica

19 September 2017

1 reference

19 September 2017

114

1 reference

19 September 2017

5

1 reference

19 September 2017

364-371

1 reference

Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer

19 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Inhibitors of tyrosine kinase inhibit the production of urokinase plasminogen activator in human prostatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Gene expression analysis of prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Summaries of Affymetrix GeneChip probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Cadherins and the tumour progression: is it all in a switch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Protein-protein interactions and cancer: small molecules going in for the kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Integrins: regulators of tissue function and cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Expression of growth factors, growth factor receptors and apoptosis related proteins in invasive breast cancer: relation to apoptotic rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2006.APM_370.X

Isolation of a human prostate carcinoma cell line (DU 145)

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910210305

Identifiers

DOI

10.1111/J.1600-0463.2006.APM_370.X

1 reference

19 September 2017

1 reference

PubMed ID

16725013